Suzhou Alphamab Co., Ltd.
PrivateLast Round
IPO
Dec 11, 2019
Est. Valuation
$1.16B
Total Funding Raised
$160M
Company Overview
Suzhou Alphamab Co., Ltd. is a biopharmaceutical company that provides research and industrialization services for antibody and protein macromolecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou Alphamab Co., Ltd. Comparables
Compare Suzhou Alphamab Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alphamab Oncology | 93% | |
| Akeso, Inc. | 86% | |
| 3D Medicines Inc. | 84% |
Suzhou Alphamab Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 11, 2019 | ||||
| Series B | May 28, 2019 | ||||
| Series A | Nov 16, 2018 |
Suzhou Alphamab Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | IPO |
| PAG | Series B, Series A |
| OrbiMed | Series A, IPO |
| Advantech Capital | Series B, Series A |
| Janchor Partners | Series A |
| Greenwoods Asset Management | IPO |
| Hudson Bay Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2025
Monthly visitors grew 350% MoM, reaching 1.5K.
- May 3, 2025
Monthly visitors grew 993% MoM, from 14 to 153.
Suzhou Alphamab Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Suzhou Alphamab Co., Ltd.'s valuation, stock price, and market status.
Is Suzhou Alphamab Co., Ltd. a public or private company?
Suzhou Alphamab Co., Ltd. is a private company.
What is the current stock price of Suzhou Alphamab Co., Ltd.?
Suzhou Alphamab Co., Ltd. is a private company with no public stock price. Caplight tracks Suzhou Alphamab Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Suzhou Alphamab Co., Ltd. worth (valuation)?
Suzhou Alphamab Co., Ltd.'s valuation is estimated at $1.2B based on funding round data.
Can I buy Suzhou Alphamab Co., Ltd. stock?
Suzhou Alphamab Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Suzhou Alphamab Co., Ltd.'s last funding round?
Suzhou Alphamab Co., Ltd.'s most recent funding round was IPO on December 11, 2019.
Who are the main investors in Suzhou Alphamab Co., Ltd.?
Key investors in Suzhou Alphamab Co., Ltd. include Hudson Bay Capital Management.
Will Suzhou Alphamab Co., Ltd. IPO soon?
No public IPO plans have been announced for Suzhou Alphamab Co., Ltd..
How can I track Suzhou Alphamab Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Suzhou Alphamab Co., Ltd.'s secondary market activity and sign up for updates.